Katherine Cheung

Title: Katherine Cheung: Innovator in Cancer Therapy

Introduction

Katherine Cheung is a notable inventor based in Paramus, NJ (US). She has made significant contributions to the field of cancer therapy through her innovative inventions. With a total of 2 patents, her work focuses on developing novel compounds that can aid in the treatment of various cancers.

Latest Patents

Katherine's latest patents include methods involving 5-(arylsulfonyl)-, 5-(arylsulfinyl)-, and 5-(arylsulfanyl)-thiazolidine-2,4-diones. These compounds are designed to inhibit farnesyl-protein transferase, which plays a crucial role in the development of ras-oncogene-dependent tumors. Her inventions may serve as alternatives or complementary treatments to traditional cancer therapies, particularly for cancers affecting the pancreas, colon, bladder, and thyroid.

Career Highlights

Katherine Cheung is currently associated with Wyeth Holdings Corporation, where she continues to advance her research and development efforts. Her work has garnered attention for its potential impact on cancer treatment and patient outcomes.

Collaborations

Katherine has collaborated with esteemed colleagues such as Joseph William Epstein and Semiramis Ayral-Kaloustian, contributing to a dynamic research environment that fosters innovation.

Conclusion

Katherine Cheung's contributions to cancer therapy through her innovative patents highlight her role as a leading inventor in the field. Her work not only showcases her expertise but also holds promise for improving treatment options for patients battling cancer.